T T Tran

Summary

Affiliation: Cedars-Sinai Medical Center
Country: USA

Publications

  1. doi request reprint Screening for hepatitis B in chemotherapy patients: survey of current oncology practices
    T T Tran
    Department of Medicine, Cedars Sinai Medical Center, UCLA School of Medicine, Los Angeles, CA 90048, USA
    Aliment Pharmacol Ther 31:240-6. 2010
  2. doi request reprint Management of hepatitis B in pregnancy: weighing the options
    Tram T Tran
    Geffen UCLA School of Medicine, Center for Liver Disease and Transplantation, Cedars Sinai Medical Center, Los Angeles, CA 90048, USA
    Cleve Clin J Med 76:S25-9. 2009
  3. ncbi request reprint Hepatitis B: epidemiology and natural history
    Tram T Tran
    Cedars Sinai Medical Center, Geffen School of Medicine, UCLA, 8635 W 3rd Street, Suite 590W, Los Angeles, CA 90049, USA
    Clin Liver Dis 8:255-66. 2004
  4. doi request reprint Understanding cultural barriers in hepatitis B virus infection
    Tram T Tran
    Geffen UCLA School of Medicine, Center for Liver Disease and Transplantation, Cedars Sinai Medical Center, Los Angeles, CA 90048, USA
    Cleve Clin J Med 76:S10-3. 2009
  5. ncbi request reprint Sirolimus-induced hyperlipidaemia in liver transplant recipients is not dose-dependent
    R J Firpi
    Center for Liver Diseases and Transplantation, Cedars Sinai Medical Center, Los Angeles, CA 90048, USA
    Aliment Pharmacol Ther 19:1033-9. 2004
  6. doi request reprint Tobacco and other factors have a negative impact on quality of life in hepatitis C patients
    D Yamini
    Hepatology Section, Division of Gastroenterology, Cedars Sinai Medical Center, Los Angeles, CA 90048, USA
    J Viral Hepat 18:714-20. 2011
  7. ncbi request reprint Comparison of clinical outcomes in chronic hepatitis B liver transplant candidates with and without hepatocellular carcinoma
    Stephen N Wong
    Division of Gastroenterology, University of Michigan, Ann Arbor, MI 48109 0362, USA
    Liver Transpl 13:334-42. 2007
  8. pmc Outcomes of patients with hepatitis B who developed antiviral resistance while on the liver transplant waiting list
    Melissa K Osborn
    University of Michigan Medical Center, Ann Arbor, Michigan 48109, USA
    Clin Gastroenterol Hepatol 5:1454-61. 2007
  9. ncbi request reprint Living donor liver transplantation: histological abnormalities found on liver biopsies of apparently healthy potential donors
    Tram T Tran
    Department of Medicine Gastroenterology, Cedars Sinai Medical Center, Geffen UCLA School of Medicine, Los Angeles, California 90048, USA
    J Gastroenterol Hepatol 21:381-3. 2006
  10. ncbi request reprint Emerging role of transplantation for primary liver cancers
    Nicholas N Nissen
    Center for Liver Diseases and Transplantation, Cedars Sinai Medical Center, Los Angeles, California, USA
    Cancer J 10:88-96. 2004

Collaborators

Detail Information

Publications12

  1. doi request reprint Screening for hepatitis B in chemotherapy patients: survey of current oncology practices
    T T Tran
    Department of Medicine, Cedars Sinai Medical Center, UCLA School of Medicine, Los Angeles, CA 90048, USA
    Aliment Pharmacol Ther 31:240-6. 2010
    ..Current recommendations include screening patients at risk for HBV prior to immunosuppressive therapy and initiating antiviral prophylaxis in patients with chronic HBV...
  2. doi request reprint Management of hepatitis B in pregnancy: weighing the options
    Tram T Tran
    Geffen UCLA School of Medicine, Center for Liver Disease and Transplantation, Cedars Sinai Medical Center, Los Angeles, CA 90048, USA
    Cleve Clin J Med 76:S25-9. 2009
    ..Careful discussion with the patient regarding the risks and benefits of therapy is warranted. Prophylaxis remains the best method of prevention of perinatal transmission...
  3. ncbi request reprint Hepatitis B: epidemiology and natural history
    Tram T Tran
    Cedars Sinai Medical Center, Geffen School of Medicine, UCLA, 8635 W 3rd Street, Suite 590W, Los Angeles, CA 90049, USA
    Clin Liver Dis 8:255-66. 2004
    ..HBeAg-negative chronic hepatitis is increasingly recognized with additional challenges in management. Programs implementing primary prophylaxis strategies such as vaccination of high-risk adult and adolescent groups should continue...
  4. doi request reprint Understanding cultural barriers in hepatitis B virus infection
    Tram T Tran
    Geffen UCLA School of Medicine, Center for Liver Disease and Transplantation, Cedars Sinai Medical Center, Los Angeles, CA 90048, USA
    Cleve Clin J Med 76:S10-3. 2009
    ..Health care providers are obligated to educate themselves regarding cultural sensitivity and to advocate for improved access to care...
  5. ncbi request reprint Sirolimus-induced hyperlipidaemia in liver transplant recipients is not dose-dependent
    R J Firpi
    Center for Liver Diseases and Transplantation, Cedars Sinai Medical Center, Los Angeles, CA 90048, USA
    Aliment Pharmacol Ther 19:1033-9. 2004
    ..Hypertriglyceridaemia is a common adverse event seen with sirolimus use, and often does not respond to dose reduction or anti-lipemic drugs...
  6. doi request reprint Tobacco and other factors have a negative impact on quality of life in hepatitis C patients
    D Yamini
    Hepatology Section, Division of Gastroenterology, Cedars Sinai Medical Center, Los Angeles, CA 90048, USA
    J Viral Hepat 18:714-20. 2011
    ..Practitioners should be aware of these associations, particularly tobacco use, which significantly and negatively impacted every variable evaluated...
  7. ncbi request reprint Comparison of clinical outcomes in chronic hepatitis B liver transplant candidates with and without hepatocellular carcinoma
    Stephen N Wong
    Division of Gastroenterology, University of Michigan, Ann Arbor, MI 48109 0362, USA
    Liver Transpl 13:334-42. 2007
    ..In conclusion, despite more advanced liver disease and a lower rate of transplantation, ITT survival of patients listed for HBV-cirrhosis was comparable to those with HBV-HCC, possibly related to beneficial effects of antiviral therapy...
  8. pmc Outcomes of patients with hepatitis B who developed antiviral resistance while on the liver transplant waiting list
    Melissa K Osborn
    University of Michigan Medical Center, Ann Arbor, Michigan 48109, USA
    Clin Gastroenterol Hepatol 5:1454-61. 2007
    ..Use of antiviral salvage therapy might decrease this risk...
  9. ncbi request reprint Living donor liver transplantation: histological abnormalities found on liver biopsies of apparently healthy potential donors
    Tram T Tran
    Department of Medicine Gastroenterology, Cedars Sinai Medical Center, Geffen UCLA School of Medicine, Los Angeles, California 90048, USA
    J Gastroenterol Hepatol 21:381-3. 2006
    ..In living donor liver transplantation, assessment of histological abnormalities that are undetectable by serological, biochemical and radiological methods might play an important role in donor and recipient outcome...
  10. ncbi request reprint Emerging role of transplantation for primary liver cancers
    Nicholas N Nissen
    Center for Liver Diseases and Transplantation, Cedars Sinai Medical Center, Los Angeles, California, USA
    Cancer J 10:88-96. 2004
    ....
  11. ncbi request reprint Carboxyhemoglobin and its correlation to disease severity in cirrhotics
    Tram T Tran
    Department of Medicine, Cedars Sinai Medical Center, Los Angeles, CA, USA
    J Clin Gastroenterol 41:211-5. 2007
    ..To assess the correlation of serum carboxyhemoglobin (CO-Hb) to severity of liver disease as compared with Model for End Stage Liver Disease (MELD) score, Child Pugh score, and clinical parameters...
  12. ncbi request reprint Advances in liver transplantation. New strategies and current care expand access, enhance survival
    Tram T Tran
    University of California, Los Angeles, David Geffen School of Medicine, Los Angeles, CA, USA
    Postgrad Med 115:73-6, 79-85. 2004
    ..Here, a team of transplant physicians highlights these new strategies, as well as the long-term management issues of special relevance to primary care physicians caring for transplant recipients...